1.
Trape G, Fianchi L, Lai M, Laurenti L, Piscitelli R, Leone G, Pagano L. Rituximab chimeric anti-CD20 monoclonal antibody treatment for refractory hemolytic anemia in patients with lymphoproliferative disorders. Haematologica [Internet]. 2003Feb.1 [cited 2026Nov.4];88(2):223-5. Available from: https://haematologica.org/article/view/2634